DAVITA INC. for DAVITA INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
End-stage renal disease reimbursement and policies related to the End Stage Renal Disease Prospective Payment System Proposed Rule; H.R. 3590 The Patient Protection and Affordable Care Act; H.R. 4994 Medicare & Medicaid Extenders Act; and H.R. 3082 Continuing Appropriations and Surface Transportation Extensions Act. Accountable Care Organization guidelines as developed by CMS.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH HAMLETT | — |
| JOHN SCHAEFFLER | Rep. Sikorski LA; Rep. Minge LD |
| JOELLE OISHI THORNHILL | House Ways & Means Comm; Sen Finance Comm |
Medicare/Medicaid MMM
End-stage renal disease reimbursement and policies related to the End Stage Renal Disease Prospective Payment System Proposed Rule; H.R. 3590 The Patient Protection and Affordable Care Act; H.R. 4994 Medicare & Medicaid Extenders Act; and H.R. 3082 Continuing Appropriations and Surface Transportation Extensions Act. Accountable Care Organization guidelines as developed by CMS.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH HAMLETT | — |
| JOHN SCHAEFFLER | Rep Sikorski LA, Rep Minge LD |
| JOELLE OISHI THORNHILL | House Ways & Means Comm; Sen Finance Comm |
Veterans VET
Proposed rule related to payments for non-departmental facilities.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH HAMLETT | — |
| JOHN SCHAEFFLER | Rep Sikorski LA; Rep Minge LD |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.